SC

Shantreddy Channareddy Soogareddy

Active Director Director DIN 10711159
DIN 10711159 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shantreddy Channareddy Soogareddy

Data last updated:

Shantreddy Channareddy Soogareddy is a Director at Celix Pharmaceuticals (India) Private Limited (since 2024). The company operates in Pharma.

DIN 10711159
Primary Designation Director
Industry Pharma
First Appointment 18 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20242024Active

Board colleagues of Shantreddy Channareddy Soogareddy

Directorship timeline

Open interactive timeline →
Celix Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Shantreddy Channareddy Soogareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shantreddy Channareddy Soogareddy

Shantreddy Channareddy Soogareddy currently holds 1 directorship: Celix Pharmaceuticals (India) Private Limited (Director, since 18 Jul 2024).

Shantreddy Channareddy Soogareddy was first appointed on 18 Jul 2024 as Director at Celix Pharmaceuticals (India) Private Limited.

The current boards of Shantreddy Channareddy Soogareddy's companies include Subramanian Vishar Vasudevan (Celix Pharmaceuticals (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available